|Year : 2006 | Volume
| Issue : 4 | Page : 266-270
The effect of Hypericum perforatum extract against the neurochemical and behavioural changes induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice
M Mohanasundari1, S Sethupathy2, M Sabesan1
1 Department of Zoology, Annamalai University, Annamalainagar-608 002, India
2 Division of Biochemistry, RMMCH, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India
Department of Zoology, Annamalai University, Annamalainagar-608 002
Source of Support: None, Conflict of Interest: None
Objective: Hypericum perforatum extract (HPE), known for its antidepressant effect, has been explored in the present study for its protective role against MPTP induced neurotoxicity.
Materials and Methods: Mice were treated with 20 mg/kg of MPTP, four injections i.p., at 2 h intervals within 24 h. HPE was administered at different doses of 100, 200 and 300 mg/kg (p.o) in different groups once a day for seven days and the dose on the first day was given 30 min prior to first MPTP injection. Striatal dopamine (DA) and its metabolites, antioxidant status were analysed. The behavioural changes were studied using the rotarod test, hang test and narrow beam test.
Results: HPE significantly ( P <0.05) improved the behavioural activities, striatal neurotransmitter levels and striatal antioxidant status in a dose dependent manner and significantly ( P <0.05) reduced TBARS levels.
Conclusion: HPE possesses significant antioxidant activity and renders neuroprotection which was more pronounced at the dose of 300 mg/kg against MPTP induced neurotoxicity.
Keywords: Neuroprotection, Parkinson′s disease, St. John′s wort.
|How to cite this article:|
Mohanasundari M, Sethupathy S, Sabesan M. The effect of Hypericum perforatum extract against the neurochemical and behavioural changes induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Indian J Pharmacol 2006;38:266-70
|How to cite this URL:|
Mohanasundari M, Sethupathy S, Sabesan M. The effect of Hypericum perforatum extract against the neurochemical and behavioural changes induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Indian J Pharmacol [serial online] 2006 [cited 2023 May 28];38:266-70. Available from: https://www.ijp-online.com/text.asp?2006/38/4/266/27023
| » Introduction|| |
Hypericum perforatum, commonly called St. John's wort, has been used for centuries as a medicinal herbal remedy. The extract of the herb is widely prescribed for the treatment of mild to moderate depression, outselling fluoxetine by a factor of four and its popularity is growing world wide. Parkinson's disease (PD) is a common neurodegenerative disorder characterised by a progressive loss of dopaminergic neurons in susbtantia nigra. Exposure of experimental animals to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) provides a valuable model of neurotoxicity with behavioural, pathological and neurochemical features remarkably similar to those of PD. L-dopa is the most efficacious antiParkinsonian drug and virtually all patients respond to its administration. However, a major limitation to the chronic use of L-dopa is the develop-ment of motor complications such as motor fluctuations and dyskinesia. With advancing disease, it becomes increasingly more difficult to deliver a dose of L-dopa that both controls Parkinsonian motor features and avoids dyskinesia.
Thus, neuroprotective strategies employing antioxidant is a good approach in improving the treatment of PD.,, There is a need to search for alternative medicine, with neuroprotective effects, without side effects, for the management of PD.
It has been recently reported that the effect of the H. perforatum extract might be mediated by an increase in brain levels of serotonin (5-HT), dopamine (DA), norepinephrine or by stimulation of opioid receptors in the central nervous system (CNS).,
The H. perforatum extract contains many phenolic compounds, namely flavonoids and phenolic acids, suggesting that they could have important antioxidant, antiinflammatory properties. The polyphenols have the ability to penetrate the blood-brain barrier by simple diffusion which fulfill the requirements for a potential neuroprotective agent. So, the present study has been designed to evaluate the dose dependent effects of HPE against MPTP induced neurotoxicity in mice.
| » Materials and Methods|| |
Male Swiss albino mice ( Mus musculus ), weighing 25-35 g, were procured from the central animal house, Department of Experimental Medicine, Rajah Muthiah Medical College, Annamalai University, Annamalainagar. The animals were maintained at the central animal house and were fed on a standard balanced diet (Hindustan Lever, Bangalore) and provided with water ad libitum . All studies were conducted in accordance with the National Institute of Health Guide.
MPTP (salt) was obtained from Sigma Chemical Co. USA and all other chemicals used were of analytical grade.
Plant material and preparation of extracts
H. perforatum plants were collected from Western Ghats of Nilgiris, Tamil Nadu and were botanically authenticated by the Department of Botany (Voucher Specimen Ac No. 2456), Annamalai University, Annamalainagar, Tamil Nadu. The leaves were air dried at room temperature, finely powdered with auto-mix blender and stored in a deep freezer until the time of use. The methanolic extract prepared using Soxhlet was concentrated by rotary evaporator at 40°C and stored in a cool place.
The animals were divided into six groups, each consisting of six mice. Group I served as vehicle control (10% Tween 80, p.o.), Group II received 300 mg/kg HPE (p.o.), Group III received 20 mg/kg MPTP four injections at 2 h intervals, i.p ., Groups IV, V and VI received HPE at the dose of 100, 200 and 300 mg/kg (p.o.), respectively. The treatment was given on the initial day, 30 min. prior to first injection of MPTP and once a day for another six days of the experimental period.
At the end of experimental period (after 7 days of treatment) the animals were fasted overnight and sacrificed by cervical decapitation before stunning. The brains were excised immediately, the striatal region was identified using the stereotaxic Atlas More Details of an albino mouse brain. The fresh brain was serially sectioned and the striatum was separated. The tissue was homogenised in ice cold 0.1% M PBS solution and used for further analysis as mentioned later.
| » Motor integration tests were assessed by different methods|| |
Motor coordination was measured on the seventh day using an automated rotarod (Amni, Rotar Instrumentation, Columbus, OH, USA). The animals were exposed to 10 trials on a rotating rod at 10 rpm at 5 min. intervals with a cut off time of 180 seconds. The rotor was divided into two compartments, which could allow two mice at a time. The average retention time on the rod was calculated.
Neuromuscular strength was determined on the seventh day in the grid hang test. The mice were lifted by their tails, slowly placed on a horizontal grid (grid 12 cm 2 opening 0.5 cm 2) and supported until they grabbed the grid with their fore and hind paws. The grid was then inverted so that the mice were allowed to hang upside down. The grid was mounted 20 cm above a hard surface to discourage falling, but not leading to injury in case of a fall. The apparatus was equipped with a 3-inch wall to prevent the animals from transversing to the upper side of the grid. The animals were required to stay on the grid for 30 seconds and 10 chances were given with 1 min intervals and the maximum hanging time was recorded. The calculation was made as percentage of hanging time
Narrow beam maze (NBM)
This maze consisted of a start-and-goal-box and the runway was made of a smooth wooden narrow beam of 180 cm length with a runway width of 2 cm. The beam was elevated off the ground by 1 meter with additional supports. The inner diameter of start-and-goal-box was 13 cm width and 40 cm high walls and the inner walls were painted black. The animals were trained in an NBM for 10 trials per day with 1 min interval. The semi-starved mice were allowed to explore the NBM for 10 trials with 1 min interval on the seventh day of experimental period and during this exploration animals were motivated and rewarded with food pellets in the goal box. The journey time between start-box-and-goal-box was measured.
Catatonia was measured by placing the animals on a flat horizontal surface with both hind limbs on a square wooden block (3 cm height): latency to move was calculated in seconds., 
| » Biochemical analysis|| |
Measurement of dopamine and DOPAC
The brain samples were weighed immediately after dissection, frozen and stored at -80°C until assay. The striatal samples were sonicated in ice-cold 0.2 M perchloric acid containing 100 mg/ml, isoproterenol as internal standard. Homogenates were centrifuged at 3000 rpm for 15 min at 4°C. The supernatant was filtered and an aliquot (30 ml) was used for the determination of dopamine and DOPAC levels using HPLC with an electrochemical detector ([ECD]; Eicom, Kyoto, Japan). The amounts of dopamine and DOPAC were calculated by comparing the simple peak with the internal standard peak and expressed as microgram per gram of tissue weight.
Estimation of lipid peroxidation products
Thiobarbituric acid was added to the brain homogenate under acidic conditions and the absorbance of colour that developed after heating was estimated spectrophotometrically at 535 nm.
Assay of superoxide dismutase (SOD EC.22.214.171.124)
SOD was assessed by the inhibition of formation of NADH-phenazine methosulphate nitroblue tetrazolium formazon. The reaction was initiated by the addition of NADH after incubation for 90s and stopped by the addition of glacial acetic acid. The colour formed at the end of the reaction was extracted into the butanol layer and measured at 520 nm.
Assay of catalase (CAT, EC.126.96.36.199)
CAT was assayed colorimetrically as per the method of Sinha. Dichromate in acetic acid was converted to perchromic acid and then to chromic acetate when heated in the presence of H 2 O 2 . The chromic acetate formed was measured at 620 nm. The catalase preparation was allowed to split H 2 O 2 for different periods of time. The reaction was stopped at different time intervals by the addition of a dichromate-acetic acid mixture and the remaining H 2 O 2 was determined colorimetrically as chromic acetate.
Assay of glutathione peroxidase (GPx EC.188.8.131.52)
GPx was estimated as described by Rotruck et al. A known amount of brain homogenate was allowed to react with H -2 O 2 in the presence of GSH for a specified time period, then the remaining GSH was allowed to react with DTNB and the developed yellow colour was measured at 412 nm.
Estimation of reduced glutathione
GSH in brain homogenate was measured according to the method of Ellman. This method is based on the development of a yellow colour when 5,5'-dithio-bis-2-nitrobenzoic acid (DTNB) is added to compounds containing sulfhydryl groups.
One way analysis of variance followed by Scheffe's test was employed for the analysis of behavioural variances and neurochemical parameters. P <0.05 was considered significant.
| » Results|| |
[Figure - 1]a depicts the results of the rotarod test. The retention time significantly decreased in the MPTP treated group when compared with the control group and it was significantly improved ( P <0.05) in 100, 200 and 300 mg/kg of HPE groups. Among HPE groups, 300 mg/kg showed marked improvement ( P <0.05) compared to 100 and 200 mg/kg.
[Figure - 1]b depicts the results of the hang test. The hang time significantly decreased ( P <0.05) in the MPTP treated group compared to the control group. The hang time significantly ( P <0.05) improved in 100, 200 and 300 mg/kg HPE treatment groups. Again in HPE groups, 300 mg/kg showed marked improvement ( P <0.05) in hanging time compared to 100 and 200 mg/kg.
[Figure - 1]c shows the results of the narrow beam test. The crossing time of 180 cm length wooden path significantly ( P <0.05) decreased in the MPTP treated animals as compared to the control group. The HPE groups 100, 200 and 300 mg/kg showed marked improvement in locomotor ability as compared to the MPTP treated group. The 300 mg/kg HPE group showed a significant improvement in the locomotor ability compared to lower doses.
[Figure - 1]d reveals the catatonic response. The latency period was significantly ( P <0.05) increased in the MPTP treated animals as compared to the control group. The 300 mg/kg HPE group showed a significant ( P <0.05) reduction in the latency period compared lower doses.
[Table - 1] displays the striatal dopamine and the metabolite levels in the control and experimental groups. Dopamine and its metabolite DOPAC and HVA markedly ( P <0.05) decreased in the MPTP treated animals while their levels significantly ( P <0.05) improved in 300 mg/kg HPE treated animals when compared to 100 and 200 mg/kg HPE treatment groups. Dopamine turnover ratio significantly ( P <0.05) increased in the MPTP group and significantly decreased ( P <0.05) in all HPE treatment groups, wherein with 300 mg/kg HPE, the decrease was marked.
Striatal TBARS and antioxidant status are presented in [Table - 2] and [Figure - 1]e. Striatal TBARS was significantly ( P <0.05) elevated in the MPTP group compared to the control group. HPE, 300 mg/kg, significantly ( P <0.05) decreased the TBARS level compared lower doses. SOD, CAT, GPx and GSH activities were significantly decreased ( P <0.05) in MPTP treated animals as compared to the control group. These activities were restored significantly ( P <0.05) in 300 mg/kg HPE group.
| » Discussion|| |
MPTP caused significant overt and subtle behavioural manifestations. The study also reveals the existence of quantitative behavioural responses within a short span of seven days in MPTP-lesioned animals to the administration of HPE in a dose dependent manner. MPTP administered mice, subjected to the rotarod test, revealed a significant loss of muscular coordination and the poor performance in the hang test. This could be due to loss of muscular strength as reported earlier. The narrow beam maze, used to test the balance and working performance, was significantly altered by MPTP treatment. MPTP also induced the catatonic response. The striatum is known to be involved in head and forelimb motor control. Altered behavioural responses in mice, following DA depletion or striatal damage, is considered to be similar to human Parkinsonism More Details.,,, In the present study, a significant reduction of striatal DA and its metabolites in MPTP treated mice was observed.
The dopamine turnover increased after MPTP intoxication in mice. This increased turnover ratio is generally considered as a compensation for dopamine depletion. Increased striatal lipid peroxidation with decreased antioxidant status was observed in MPTP treated animals.
HPE prevented the motor impairment in a dose dependent manner and also decreased the latency period of catatonic behaviour, altered by MPTP. The animals which were administered 300 mg/kg HPE had a significant improvement than those which received lower doses. The loss of striatal dopamine was at least partially prevented when mice were administered HPE at various doses and the beneficial effect was maximum at 300 mg/kg than with other doses.
Recently, hyperforin, the fluoroglucinol derivative of HPE has gained interest, as it represents the major component responsible for the inhibition of the uptake of several neurotransmitters in vitro. HPE as well as hyperforin treatment modulates neurotransmitter levels in the brain of rodents. In addition, there are several reports on HPE inhibiting dopamine reuptake., Due to this mechanism, the dopamine level was retained in the synaptic region. It has been reported that MAO-B inhibition was evident with H.perforatum extract fractions containing higher concentrations of flavonoids., Possibly due to inhibition of MAO-B, conversion of MPTP to MPP+ is decreased resulting in decreased lipid peroxidation. In the present study, HPE reduced the MPTP induced lipid peroxidation (TBARS) in a dose dependent manner. Silva et al. also demonstrated a significant protection against ascorbate/ Fe 2+ induced lipid peroxidation by ethanolic extract of HPE, in rat cortical synaptosomes.
Hunt et al. evaluated the antioxidant effect of HPE against the superoxide anion and demonstrated that a free radical-scavenging effect for most of the concentrations tested. They postulated that this effect could be related to its content in hypericin. In the present study, HPE effectively improved the antioxidant enzyme activities such as SOD, CAT and GPx in MPTP treated animals especially at the dose of 300 mg/kg. So, it is concluded that HPE can exert a significant neuroprotective effect and its usefulness in the management of Parkinson's disease needs exploration.
| » References|| |
|1.||Marsh WL, Davies JA. The involvement of sodium and calcium ions in the release of amino acid neurotransmitters from mouse cortical slices elicited by hyperforin. Life Sci 2002;71:2645-55. [PUBMED] [FULLTEXT]|
|2.||Lang AP, Lozano AE. Parkinson's disease. New Engl J Med 1998;339: 1044-53. |
|3.||Olanow CW, Schapira AHV, Rascol O. Continuous dopamine-receptor stimulation in early Parkinson's disease. TINS 2000;23:117-26. |
|4.||Levites Y, Weinreh O, Maor G, Youdim MBH, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001;78:1073-82. |
|5.||Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Evans CR. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 1995;322:339-46. |
|6.||Bastianetto S, Ramasamy C, Dore S, Christen Y, Poirier J, Quirion R. The Gingobiloba extract [EGb-761] protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 2000;12:1882-90. |
|7.||Butterweck V, Wall A, Lieflander-Coulf U, Winterhoff H, Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 1997;30:117-24. |
|8.||Silva BA, Ferreres F, Malva J, Dias ACP. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts. Food Chem 2005;90: 157-67. |
|9.||Panocka I, Perfumi M, Angeletti S, Ciccocioppo R, Mass M. Effects of Hypericum perforatum extract on alcohol intake and on behavioural despair: A search for the neurochemical systems involved. Pharmacol Biochem Behav 2000;66:105-11. |
|10.||Jackson-Lewis V, Jacowec M, Burke RE, Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 1995;4:257-69. |
|11.||Slotnick BM, Leonard CM. A stereotaxic atlas of the albino mouse forebrain. Rockville, Maryland: Alcohol, Drug Abuse and Mental Wealth Administration, 1975. |
|12.||Rozas G, Liste I, Guerra HJ, Labandesia JL. An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of Parkinsonism. Brain Res Protocols 1995;245:151-4. |
|13.||Tillerson JL, Michael Caudle W, Reverson ME, Miller GW. Detection of behavioural impairments correlated to neurochemical deficits in mice treated with moderate dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol 2002;178:80-90. |
|14.||Fernagut PO, Diguet E, Bioulac B, Tison F. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Exp Neurol 2004;185:47-62. |
|15.||David J, Kaul CL, Grewal RS. Pharmacological and biochemical characterization of anti-Parkinson drugs in reserpinised mice. Indian J Exp Biol 1979;17: 764-66. |
|16.||Muralikrishnan D, Mohanakumar KP. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurotoxicity in mice. FASEB J 1998;12:905-12. |
|17.||Kato H, Araki T, Imai Y, Jakahashi A, Itoyama Y. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease. J Neurol Sci 2003;208:9-15. |
|18.||Ohkawa H, Ohishi W, Yahik K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-58. |
|19.||Kakkar P, Das B, Viswanathan PW. Modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130-2. |
|20.||Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94. |
|21.||Rotruck JT, Pope AL, Ganthor HE, Swanson AB. Selenium biochemical role as a component of glutathione peroxidase. Science 1973;179:588-90. |
|22.||Ellman GC. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7. |
|23.||Cousins MS, Salamone JD. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience 1996;70:849-59. |
|24.||Cousins MS, Salamone JD. Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization. Brain Res 1996;732:186-94. |
|25.||Pisa M. Regional specialization of motor functions in the rat striatum: implications for the treatment of Parkinsonism. Prog Neuro Pharmacol Biol Psy 1998;12:217-24. |
|26.||German DC, Nelson EC, Liang CL, Speciale SG, Sinton CM, Sonsalla PK. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration 1996;5:299-12. |
|27.||Chatterjee SS, Noldner M, Koch E, Erdelmeierc M. Antidepressant activity of H. perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 1998;31:7-15. |
|28.||Serdarevic N, Eckert GP, Nuller WE. The effects of extracts from St. John's Wort and Kava kava on brain neurotransmitter levels in the mouse. Pharmacopsychiatry 2001;34:134-6. |
|29.||Kaehler ST, Sinner C, Chatterjee SS, Phillippu A. Hyperforin enhances the extracellular concentrations of catecholamine, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett 1999;262:199-02. |
|30.||Hunt EJ, Lester CE, Lester EA, Tackett RL. Effects of St. John's Wort on free radical production. Life Sci 2001;67:181-90. |
|31.|| Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatry Neurol 1994;7:57-9. |
|32.||El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary ES. Hypericum perforatum extract demonstrated antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 2003;76:525-33. |
[Figure - 1]
[Table - 1], [Table - 2]
|This article has been cited by|
||Natural antioxidants in the management of Parkinson’s disease: Review of evidence from cell line and animal models
| ||Reem Abdul-Latif, Ieva Stupans, Ayman Allahham, Benu Adhikari, Thilini Thrimawithana |
| ||Journal of Integrative Medicine. 2021; 19(4): 300 |
|[Pubmed] | [DOI]|
|| Anti-anxiety, anti-depressant and anti-cataleptic activity of 4-hydroxy-3-[2-(3-nitrophenyl)-2, 3-dihydro-1, 5-benzothiazepin-4-yl]-2h-chromen-2-one
| ||Shanish, A.A., Pal, B., Aditya, S., Rakesh, V., Mehul, G., Ankit, P., Sindhura, G. |
| ||Pharmacologyonline. 2010; 3: 470-478 |
||Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinsonæs disease in mice
| ||Mohanasundari, M., Sabesan, M. |
| ||European Review for Medical and Pharmacological Sciences. 2007; 11(1): 17-20 |